$ECX

ECARX (ECX) director Grace Hui Tang lists vested options in Form 3

ECARX Holdings Inc. director Grace Hui Tang filed a Form 3, an initial ownership report, disclosing her holdings of fully vested stock options. These options allow her to purchase Class A Ordinary Shares at an exercise price of $0.5000, with expiration dates ranging from 2033 to 2035. This filing clarifies her potential ownership position rather than reporting new transactions.

Original reporting
Published Mar 19, 2026, 4:08 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 19, 2026, 4:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ECX
Neutral
medium confidence
Mentioned
$ECX
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$ECXNeutralLow
01

Why it matters

The filing indicates potential increased insider ownership but does not provide concrete evidence of imminent market moves.

02

Market read

This news has limited immediate trading relevance but may be of interest to long-term investors monitoring insider holdings.

03

What to watch

The timing of the filing and the absence of recent transactions suggest limited immediate impact; broader market conditions should be considered.

Timing: low

Background

ECARX Holdings Inc. is a company involved in automotive technology, with insider filings often scrutinized for potential future ownership changes.

Company-level read

Ticker impact

$ECXNeutralMedium confidence
Context

The filing of a Form 3 by a director indicates potential insider interest but does not necessarily imply immediate market impact.

Expected impact

Minimal short-term price movement expected

Evidence & confidence

Insider filings are common and do not always lead to market reactions; without additional context, the impact remains limited.

Market effects

Limited; no immediate sector-wide changes indicated

Minimal; no regional effects expected

Negligible; specific to company insider activity

Counterpoint

Some investors might interpret insider activity as a positive signal for future growth, potentially leading to increased buying interest.

Key entities

  • Grace Hui Tang

    Board member of ECARX Holdings Inc.

Related articles

$ECXMedAI 8/10

ECARX (ECX) Q2 2026 Earnings Call Transcript

ECARX reported Q2 2026 revenue of $225.2M, up 45% YoY, driven by higher-value products and demand outside China. Gross margin expanded to 19.8% from 10.8% YoY. Adjusted EBITDA turned positive at $0.5M, and net loss narrowed to $12.0M. The company reaffirmed full-year guidance of $1B-$1.1B revenue, citing strong order backlog and second-half seasonality. Management highlighted growth in high-end Antora and Pikes solutions, operational efficiencies, and strategic acquisitions like Flyme. Risks inc

$ECXMed

ECARX Targets Global Growth With AI, Silicon and Automaker Partnerships

ECARX (NASDAQ:ECX) said it has expanded global R&D, with about 800 to 900 employees in China, ~200 in Europe, and ~150 in East and Southeast Asia, including sites supporting Volvo and other automakers. The company updated revenue guidance to $1.1B to $1.2B, cited Q2 revenue of $225M and gross margin near 20%, and targets AI silicon and software investments.

$ECXMedAI 8/10

ECARX shares rise as Q2 revenue jumps 45% and losses narrow

ECARX Holdings Inc. (NASDAQ:ECX) shares rose premarket after Q2 results. For quarter ended June 30, revenue increased 45% YoY to $225.2M. Net loss narrowed to $12.0M, or -$0.03 per share. Gross margin rose to 19.8% and adjusted EBITDA turned positive at $0.5M. Company kept 2026 revenue guidance at $1.0B-$1.1B but warned memory costs may pressure margins.

$ECXMedAI 8/10

Why is Ecarx stock climbing today?

Ecarx shares rose 3.7% in pre-open after the company reported unaudited Q2 2026 results. Revenue was $225.2M, up 45% year over year, while net loss narrowed to $12.0M from $45.4M. Gross margin rose to 19.8% and adjusted EBITDA stayed positive for a fourth straight quarter. Ecarx reiterated 2026 revenue guidance of $1.0B to $1.1B.

$ECXMed

ECARX Holdings Inc. (ECX): Financial results for Q2 2026

ECARX Holdings Inc. (ECX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 ECARX Announces Second Quarter 2026 Unaudited Financial Results London, August 11, 2026 — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a leading global automotive intelligence company, today announced unaudited financial results for the quarter ended

$ECXMed

ECARX-Backed Chip Maker SiEngine Secures US$200M Equity Financing to Accelerate Vertical Silicon-to-Software SDV Innovation

LONDON, July 31, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) recognises today's key update from SiEngine Technology Co., Ltd., its incubated automotive semiconductor investment. SiEngine has secured US$200 million in new equity capital from institutional investors over the course of H1 2026, hitting a transformative funding milestone as one of China's top vehicle-grade semiconductor designers.